Colossal
PrivateLast Round
Series C
Extension
Sep 17, 2025
Est. Valuation
$10.32B
Total Funding Raised
$545M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Colossal Laboratories & Biosciences is a bioscience and genetic engineering company dedicated to developing innovative technologies aimed at advancing genomics, including species de-extinction and ecosystem restoration through the application of CRISPR technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, ML Platforms
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Data as a Service
AI Layer
Application
Keywords
Price History
Caplight MarketPrice™ estimate for Colossal, published with a 90-day delay.
Caplight MarketPrice™
$8.37
per share, as of June 2026
-61.2%
1-year change
Caplight MarketPrice™ is an estimate of private secondary market pricing, shown here on a delayed basis for illustrative purposes only. It may be incomplete, is subject to change, and may not be relied upon for any purpose or considered investment advice.
Colossal Comparables
Compare Colossal with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Revive & Restore | 71% | |
| Ginkgo Bioworks | 61% | |
| Los Angeles Project | 56% |
Colossal Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Sep 17, 2025 | ||||
| Series C | Jan 15, 2025 | ||||
| Series B | Jan 31, 2023 | ||||
| Grant | Oct 5, 2022 | ||||
| Series A | Mar 9, 2022 | ||||
Seed | Sep 13, 2021 |
Secondary Market Activity
Bids, offers, and trades by month
| Operation | Date | Price | Size | Share Class | Structure |
|---|---|---|---|---|---|
OFFER | |||||
BID |
Key People
Founding team and executive leadership
Colossal Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| TWG Global | Series C |
| S32 | Series A |
| Breyer Capital | Series C, Series B, Series A, Seed |
| Global Space Ventures | Seed |
| Untamed Planet | Series A |
| US Innovative Technology Fund | Series B |
| Builders VC | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 30, 2026
Partnered with Endangered Wildlife Trust for bluebuck rewilding.
- Apr 21, 2026
Won a gold Edison Award for mammalian cloning method.
Recent news
Latest coverage and updates
- is_developingSep 27, 2026
Colossal is developing cold-adapted, mammoth-like elephant on Sep 27th '26.
- is_developingSep 17, 2026
Colossal is developing regulatory-compliant rewilding roadmap for potential habitat restoration.
- partners_withSep 17, 2026
Colossal partners with Re:wild.
- attends_eventSep 14, 2026
Colossal will attend event TechCrunch Disrupt 2026 on Oct 1st '26.
- partners_withAug 24, 2026
Colossal partners with Paramount Group.
Colossal Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessAppears On
Curated lists and screens where this company is featured.
Frequently Asked Questions
Common questions about Colossal's valuation, stock price, and market status.
Is Colossal a public or private company?
Colossal is a private company.
What is the current stock price of Colossal?
Colossal is a private company with no public stock price. Caplight tracks Colossal's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Colossal worth (valuation)?
Colossal's valuation is estimated at $10.3B based on funding round data.
Can I buy Colossal stock?
Colossal shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Colossal's last funding round?
Colossal's most recent funding round was Series C Extension on September 17, 2025.
Who are the main investors in Colossal?
Key investors in Colossal include TWG Global, Breyer Capital, US Innovative Technology Fund, At One Ventures, Tull Investment.
Will Colossal IPO soon?
No public IPO plans have been announced for Colossal.
How can I track Colossal secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Colossal's secondary market activity and sign up for updates.